Back to
FARALLON CAPITAL MANAGEMENT, L.L.C.
HZNPShowing 0 of 13 quarters
Position history for
FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in HORIZON THERAPEUTICS PUB L
As of its Q3 2023 13F, Farallon Capital Management held 6,656,823 shares of HZNP (Horizon Therapeutics Pub), worth $770.1M. Farallon Capital Management's 13F filings listed HZNP from Q2 2021 to Q3 2023, 10 quarterly filings. HZNP was 3.6% of Farallon Capital Management's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of HZNP: Pentwater Capital Management LP, FMR LLC